Syntellix AG was founded in Hanover in 2008, under the leadership of Prof Utz Claassen. The startup develops magnesium-based implants, which are used after bone fractures and then disperse in the body. Using a network of outstanding scientists, the company has been able to develop a material (MAGNEZIX®), which breaks down completely in the body, despite its high strength, and is then replaced by bone tissue. Managing Director Claassen explains how the implants work and why Syntellix products can reduce risks associated with operations.“
No ha aceptado ver este artículo. Aquí puedes mostrar el contenido. Está enviando contenido a un tercero.